The Lumenis M22 is an intense pulsed light (IPL) device designed specifically to target and reduce the appearance of vascular marks—the persistent red or purple discoloration left behind after acne heals. By delivering controlled bursts of broad-spectrum light energy, the M22 selectively heats the small blood vessels and hemoglobin in vascular lesions, causing them to collapse and be absorbed by the body over time. For many people struggling with post-acne redness that won’t fade on its own, the M22 offers a clinically proven way to diminish these marks without invasive surgery or removing healthy skin.
The device works on a simple principle: different chromophores (light-absorbing molecules) in skin respond to different wavelengths. Hemoglobin in dilated vessels absorbs light in the 515–1100 nanometer range, making IPL technology effective at treating post-inflammatory erythema and vascular lesions. Most patients see noticeable improvement after three to six treatments spaced four to six weeks apart, though results vary depending on the depth and age of the vascular marks, skin tone, and individual healing response. This article explores how the M22 works, who it’s best suited for, what to expect during treatment, realistic results, potential side effects, and how it compares to other acne mark treatments like laser therapy and chemical peels.
Table of Contents
- How Does the Lumenis M22 Target Vascular Acne Marks?
- What Results Can You Realistically Expect?
- The M22 and Different Types of Post-Acne Marks
- Treatment Protocol and What to Expect During Sessions
- Side Effects and Risks to Consider
- M22 vs. Other Vascular Mark Treatments
- Long-Term Outcomes and Future Acne Prevention
- Conclusion
- Frequently Asked Questions
How Does the Lumenis M22 Target Vascular Acne Marks?
The M22 emits a spectrum of light wavelengths that pass through the skin’s surface to reach the deeper vascular lesions. When these wavelengths encounter hemoglobin in dilated blood vessels, the blood absorbs the light energy and converts it to heat. This thermal damage causes the vessel walls to collapse, and over the following weeks, the body’s natural healing process breaks down and reabsorbs the vessel, gradually reducing the visible redness. Unlike laser therapy, which delivers a single narrow wavelength, the M22’s broad-spectrum approach can treat multiple types of vascular issues simultaneously—both fine telangiectasia (tiny broken vessels) and larger dilated capillaries respond to the same treatment. The M22’s handpiece includes both non-ablative and ablative filters, allowing practitioners to customize treatment depth and intensity.
For vascular marks specifically, non-ablative filters are typically used to avoid damaging the skin’s surface while still penetrating deep enough to reach the problem vessels. A typical treatment session involves a trained technician applying cooling gel, positioning the handpiece against the skin, and delivering pulses across the affected area. Most patients describe the sensation as a series of small snaps or pinches, often compared to the flick of a rubber band against the skin. However, the M22 works best on vascular marks that are still relatively recent or active. Older marks that have fully matured into flat, pale scars may not respond as well because they contain less active hemoglobin. In these cases, the device may still provide some benefit, but the improvement is often more modest than with fresh, red post-inflammatory erythema.
What Results Can You Realistically Expect?
Clinical studies show that most patients achieve 50–70% improvement in vascular erythema after a series of three to six M22 treatments. The timeline matters significantly: some redness improvement becomes visible within the first week as inflammation subsides, but the most dramatic results typically emerge over two to three months as the body continues to reabsorb the treated vessels. Complete clearance after a single session is rare; vascular marks are persistent, and the M22 works incrementally, with each treatment building on the last. skin tone plays a measurable role in both effectiveness and safety. The M22 works most predictably on fair to medium skin tones with clear contrast between the vascular mark and surrounding skin.
Patients with darker skin tones may achieve good results, but the treatment requires more conservative settings to avoid damaging melanin in the skin, which can also absorb the IPL light. This trade-off means that darker skin may require more sessions to see the same degree of improvement. Additionally, vascular marks that are very old or have settled into flat, white scars respond poorly because they contain less hemoglobin for the light to target. For active, bright-red post-acne redness, the M22 often delivers noticeable improvement—sometimes visible improvement after one or two treatments. However, if your vascular marks are part of a pattern of ongoing acne or persistent inflammation, treating the vascular marks alone without addressing the underlying acne may leave you with new marks forming while older ones fade.
The M22 and Different Types of Post-Acne Marks
Post-acne marks fall into several categories, and the M22’s effectiveness varies by type. Vascular erythema—the red or pink discoloration caused by inflammation and dilated blood vessels—is the M22’s primary target and responds most reliably. Poikiloderma, a combination of vascular and pigmentary changes that creates mottled redness and discoloration, also responds well because the M22 targets the vascular component. On the other hand, atrophic or depressed scars (indented, pitted marks) are structural problems that the M22 alone cannot fix. These scars require treatments like subcision, dermal fillers, microneedling, or laser resurfacing to rebuild skin texture and volume.
Some patients have a mix of vascular marks and mild scarring. In these cases, the M22 can address the redness while leaving the depressed portions unchanged, and combination therapy with other treatments may be necessary for complete improvement. A dermatologist’s evaluation is essential because what appears to be a vascular mark may actually be a combination issue that requires a tailored treatment plan. The M22 also works on other vascular lesions beyond acne—like rosacea, port-wine stains, and sun-induced capillary dilation—which is why practitioners have such fine-tuned settings. Understanding your specific mark’s composition helps set realistic expectations for what a course of M22 treatment can accomplish.
Treatment Protocol and What to Expect During Sessions
A typical M22 treatment session lasts 20–45 minutes depending on the area being treated. Before the procedure, your practitioner will cleanse the skin, apply ultrasound gel or a cooling medium, and may apply topical anesthetic if you have a low pain threshold (though most people tolerate the procedure without anesthesia). The practitioner then positions the handpiece and delivers pulses across the vascular marks, slightly overlapping each pulse zone to ensure even coverage. You’ll see immediate erythema (redness and swelling) in the treated area—this is expected and usually subsides within a few hours to a day. Post-treatment care is relatively straightforward compared to ablative laser therapy.
You should avoid sun exposure, heat (saunas, hot showers, intense exercise), and retinoids for the first 48 hours. Broad-spectrum SPF 30+ sunscreen is essential for at least two weeks because the M22 makes skin temporarily more sun-sensitive, and sun exposure can trigger pigmentation changes or undo treatment results. Some patients experience mild bruising or temporary crusting, especially on larger or deeper vascular marks; this is normal and typically resolves within a few days. The spacing between treatments—usually four to six weeks—allows time for inflammation to resolve and the body to reabsorb treated vessels. Coming back too soon doesn’t accelerate results and increases the risk of side effects. Conversely, spacing treatments too far apart (months apart) can reduce the cumulative effect because the skin “forgets” the previous treatment signals.
Side Effects and Risks to Consider
The M22 is non-invasive and well-tolerated, but it’s not side-effect free. The most common temporary effects are immediate redness, mild swelling, and occasional petechiae (small red spots from minor vessel rupture) that resolve within days. More serious but less common side effects include burns, permanent hyperpigmentation (especially in darker skin tones), hypopigmentation (lightening of skin), and post-inflammatory erythema that makes the area appear redder for weeks before improving. One frequently overlooked risk is treating active acne at the same time as vascular marks. If you’re experiencing active breakouts or inflamed lesions, the M22 can heat and potentially worsen the inflammation. This is why acne should be under control before starting a vascular mark treatment series.
Additionally, certain medications—particularly photosensitizing drugs like doxycycline, tretinoin (Retin-A), or isotretinoin (Accutane)—require treatment pause periods or adjusted settings. If you’re taking any medication that affects sun sensitivity, inform your practitioner before starting. Unrealistic expectations are another significant issue. Some patients expect one treatment to erase all vascular marks, then become frustrated when they see gradual improvement. Setting a realistic timeline and understanding that you’re managing a skin condition, not permanently curing it, is essential. Some vascular marks may return over months or years as new vessels form or inflammation recurs, particularly if the underlying acne tendency persists.
M22 vs. Other Vascular Mark Treatments
For vascular post-acne marks specifically, the M22 competes with several other treatment modalities. Pulsed dye laser (PDL) therapy is often considered the gold standard for vascular lesions and may actually be more selective for hemoglobin than the M22, but PDL is typically more expensive and less available. Both achieve similar results for pure vascular marks, though PDL may cause more purpura (bruising) immediately post-treatment.
Newer technologies like long-pulsed Nd:YAG lasers penetrate deeper and work well on resistant or deeper vascular marks but carry higher risk of scarring in inexperienced hands. The M22’s broader spectrum and flexibility make it safer for practitioners to achieve good results on a wider range of skin tones and mark depths. Chemical peels and microneedling address texture and some mild pigmentation but are less effective at eliminating the redness caused by active vascular dilation. For combined vascular plus structural scarring, many dermatologists recommend a combination approach: M22 or laser for vascular marks plus subcision, microneedling, or filler for depressed scars.
Long-Term Outcomes and Future Acne Prevention
After completing a course of M22 treatments, the improvement in vascular marks can last months to years, but it is not permanent. Factors like ongoing sun exposure, returning acne, rosacea triggers, or natural aging that increases skin fragility can lead to new or recurrent vascular lesions. Maintenance treatments spaced 6–12 months apart are often recommended for those prone to vascular issues, particularly if acne recurs.
The M22 also represents a shift in how dermatology approaches post-acne care. Rather than accepting permanent marks or pursuing invasive surgical options, light-based treatments now allow many patients to achieve significant improvement with minimal downtime. As IPL technology continues to improve—with better filtration, cooling systems, and customizable parameters—effectiveness and safety will likely increase, especially for traditionally difficult-to-treat skin tones.
Conclusion
The Lumenis M22 effectively reduces the appearance of acne vascular marks through selective photothermolysis, targeting the hemoglobin in dilated blood vessels and causing them to collapse and fade over time. For patients with post-inflammatory erythema or vascular lesions that have persisted for months, the M22 offers a non-invasive, well-tolerated path to significant improvement—typically requiring three to six treatments spaced weeks apart, with 50–70% reduction in redness as a realistic outcome.
Success with the M22 depends on realistic expectations, proper patient selection (active acne should be controlled first), conservative treatment of darker skin tones, and consistent post-treatment sun protection. While it excels at vascular erythema, the device cannot fix depressed or atrophic scars alone, and its results are not permanent—maintenance treatments or complementary therapies may be needed for complete improvement or long-term management. If you’re struggling with red acne marks that won’t fade, consultation with a dermatologist experienced in IPL technology can determine whether the M22 is right for your specific mark type and skin characteristics.
Frequently Asked Questions
How many M22 treatments do I need to see results?
Most patients see noticeable improvement after two to three treatments, with maximum results typically visible after four to six sessions. Results continue improving for several weeks to months after the final treatment as the body reabsorbs treated vessels.
Can the M22 treat active acne, or just the scars?
The M22 is primarily designed for post-acne marks, not active acne. Treating active inflamed lesions can worsen inflammation. Acne should be cleared or well-controlled before starting M22 vascular mark treatments.
Is the M22 safe for dark skin?
Yes, but with important qualifications. The broad melanin content in dark skin can absorb IPL light, so treatment requires more conservative energy settings. This typically means more sessions needed for the same result. In experienced hands, dark skin can achieve excellent outcomes, but the risk of pigmentation changes is higher than in lighter skin tones.
How long do M22 results last?
Results typically last 6–24 months, depending on skin type, sun exposure, and whether acne recurs. Some vascular marks may gradually return as new inflammation occurs or skin ages. Maintenance treatments every 6–12 months can extend results.
What’s the difference between M22 and laser therapy for vascular marks?
The M22 uses broad-spectrum IPL light, while lasers emit a single wavelength. Both are effective for vascular marks, but lasers like PDL may be more selective for hemoglobin. The M22 offers more flexibility for different mark depths and skin types, and is often more accessible and affordable.
Can I combine M22 with other acne scar treatments?
Yes. Many dermatologists use M22 for vascular erythema combined with microneedling, fillers, or subcision for depressed scars. Timing between treatments should follow your dermatologist’s protocol to avoid excessive trauma.
